Provider
P30-17 New Drug-Related Prior Authorization (PA) Criteria: Topical Retinoids
Program effective Date: Jun 05, 2017
Search Results
Displaying 2821 - 2830 of 4179 results
Provider
P41-18 Update: Change to TPA Business
Program effective Date: Sep 04, 2018
Provider
P46-17 Addition of Drug to the Self-Administered Oncology PA with Quantity Limit Program
Program effective Date: Aug 14, 2017
Provider
P12-18 New Medical, Medical Drug and Behavioral Health Policy Management Updates for Commercial Lines of Business - Effective June 4, 2018
Program effective Date: Apr 02, 2018
Provider
P10-18 Blue Cross Will Cease Mailing Certain Provider Bulletins
Program effective Date: Mar 01, 2018
Provider
P19R1-17 New Remittance Code: OA-45 for Purchased/Referred (PRC)-Eligible Subscribers
Program effective Date: Oct 24, 2017
Provider
P8-18 Changes to PA for Hip Arthroplasty, Hip Resurfacing and Knee Arthroplasty for Commercial and Government Programs Lines of Business
Program effective Date: Feb 08, 2018
Provider
P78-17 Cotiviti to Perform Inpatient Claims Reviews
Program effective Date: Dec 12, 2017
Provider
P54-17 Clarification to Commercial Prior Authorization Requirements for Early Intensive Behavioral Intervention (EIBI)
Program effective Date: Oct 10, 2017
Provider
P23-18 Clinical Reviews for Court-Ordered Substance Use Disorder Treatment
Program effective Date: Jun 01, 2018